Navigation Links
Gallo Research Center announces new round of awards for $20m US Army-funded research program

The UCSF-affiliated Ernest Gallo Clinic and Research Center has issued a second round of grants under its U.S. Army-funded research program intended to accelerate the discovery and development of new medications to treat alcohol and substance abuse in the context of post-traumatic stress and combat injury.

The program, known as the Institute for Molecular Neuroscience (IMN), relies on the expertise of a team of national experts who are unaffiliated with grant applicants to conduct an independent peer-review process.

The second round of pilot research grants will support a broad range of projects to investigate potential new treatments for substance abuse, traumatic brain injury and post-traumatic stress. The total funding for this round of awards is $1.25 million. Together with the $3.7 million awarded in round one, the IMN has to date awarded approximately $5 million in proof-of-principle grants.

The IMN Program represents an important new strategy for combating substance abuse and related post-traumatic stress or other combat injuries, said John A. De Luca, PhD, chairman of the board and president of the Gallo Center. These medical conditions are national security health issues. The IMN seeks to address these problems through its multidisciplinary, competitive national research program.

Grant recipients in this round of funding are:

Michael E. Charness

Boston VA Research Institute (Harvard)


Lori A. Knackstedt

University of Florida


Kenneth M. Lattall

Oregon Health and Science University


Eric P. Zorilla

The Scripps Research Institute


It is gratifying that Congress and the Defense Department have embraced the IMN Program and its new approach to accelerating the discovery of new medications to address substance abuse, post-traumatic stress and other conditions facing our military personnel and veterans, said William R. Sawyers, chief administrative officer of the IMN and the Gallo Center.

The UCSF-affiliated Gallo Research Center was selected to manage the IMN Program in recognition of its expertise in the neurobiology of addiction and in managing large research projects. The strategy of the IMN, which funds short-term pilot projects, and then selects only the most compelling for advancement, represents a new approach to the development of medications for the U.S. Military.

The IMN Program is comprised of a consortium of 18 leading research universities and research institutions across the country. Institutions which have received IMN funding previously include Columbia University, Oregon Health and Science University, the Medical University of South Carolina, Yale University, the University of Texas, Austin, the Northern California Institute for Research and Education (NCIRE) and UCSF.

Congressional appropriations for the IMN Program to date total $20.1 million, said De Luca. Later this year, the IMN will select the most promising of its first round of pilot projects to be advanced into the next stage of medications development, said Sawyers.


Contact: Peter Farley
University of California - San Francisco

Related medicine news :

1. Gallo Research Center to lead $15 million US Army-funded national research program
2. Increasing dopamine in frontal cortex decreases impulsive tendency, UCSF-Gallo scientists find
3. Increasing dopamine in brains frontal cortex decreases impulsive tendency, UCSF-Gallo study finds
4. Does gallows humor among physicians encourage accusations of murder and euthanasia?
5. A Milestone: Pool Services Technologies Just Conserved 7.5 Million Gallons of Water in San Diego
6. Gallo Center study in mice links cocaine use to new brain structures
7. Automotive Paints Market Worth 998.7 Million Gallons by 2018 with Revenue of $11.7 Billion - New Report by MarketsandMarkets
8. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
9. NIH awards $20 million over 5 years to train next generation of global health researchers
10. Researchers develop a new cell and animal model of inflammatory breast cancer
11. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
Post Your Comments:
Related Image:
Gallo Research Center announces new round of awards for $20m US Army-funded research program
(Date:11/27/2015)... ... ... ProSidebar: Fashion is a set of 30 kinetic edge graphics ... editors can easily add an informative sidebar to any FCPX production. Create lists, ... self-animating drop zones, lines, bars, and text with the ease of FCPX's drag and ...
(Date:11/27/2015)... ... 2015 , ... The moment you stop improving is the ... the needs of advisers and clients but going above and beyond to find ... service. However, there's always room for improvement, which is why the entire Consulting ...
(Date:11/27/2015)... ... , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces his search ... one of Joplin's most famous and beautiful concert posters. The concert was held on ... Arbor. The According to Hawley, "It is hard to believe that Joplin's stardom was ...
(Date:11/26/2015)... ... November 26, 2015 , ... Somu Sivaramakrishnan announced ... franchise owner, Somu now offers travelers, value and care based Travel Services, including ... sales, as well as, cabin upgrades and special amenities such as, shore excursions, ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film Studios brings Final ... ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, ... giving users limitless opportunities to stylize and create designs quickly and easily, all ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... has found that immunotherapy can be efficiently ...
(Date:11/26/2015)... STOCKHOLM , November 26, 2015 ... the potential to use SyMRI to find optimal contrast weighting ... brain tumor metastases, and has signed a research agreement with ... at the hospital. Using SyMRI, it is possible to generate ... parameter settings after the patient has left, thus making it ...
(Date:11/26/2015)... , November 26, 2015 3D bioprinting ... 2022, according to a new report by Grand View Research ... Disease (CKD) which demands kidney transplantation is expected to boost ... effective substitute for organ transplantation. --> 3D bioprinting ... 2022, according to a new report by Grand View Research ...
Breaking Medicine Technology: